FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Yan Xue und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Med…. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Peptides, Cyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Innovation Capability Development Project of Jiangsu Province, Wuxi Health and Family Planning Commission, Wuxi Science and Technology Association.
Abstract (Originalsprache)
FGFR1 overexpression is strongly correlated with tumorigenesis, malignant progression, and poor clinical outcomes of nonsmall cell lung cancer (NSCLC). The development of PET radiotracers specifically targeting FGFR1 holds significant clinical value for guiding FGFR1-targeted therapy, evaluating treatment efficacy, and monitoring drug resistance. In this study, we used computational simulation approaches to develop linear peptide RY9 along with cyclic peptides cRY9 and cRY9M, derived from FGF2, a particular ligand of FGFR1, and designed FGFR1-targeting radiotracers [ 68 Ga]Ga-NOTA-RY9, [ 68 Ga]Ga-NOTA-cRY9 and [ 68 Ga]Ga-NOTA-cRY9M for detecting the FGFR1 expression. In comparison to [ 68 Ga]Ga-NOTA-RY9 and [ 68 Ga]Ga-NOTA-cRY9, [ 68 Ga]Ga-NOTA-cRY9M demonstrated superior FGFR1-binding affinity, enhanced in vivo stability, and a significantly improved tumor-to-background ratio (TBR). Notably, PET imaging revealed that [ 68 Ga]Ga-NOTA-cRY9M exhibited significant and specific tumor uptake in FGFR1-positive NSCLC cell-derived xenograft (CDX) models and patient-derived xenograft (PDX) models. These results demonstrate that the cyclic peptide-based radiotracer [ 68 Ga]Ga-NOTA-cRY9M serves as a potential diagnostic agent for FGFR1-expressing tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu 214063, China.
- Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, China.
- Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China.
- Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China.
- Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
Förderung
- Innovation Capability Development Project of Jiangsu Province
- Wuxi Health and Family Planning Commission
- Wuxi Science and Technology Association
- Basic Research Program of Jiangsu Province
- Wuxi Municipal Bureau on Science and Technology
- National Natural Science Foundation of China
- Jiangsu Commission of Health
- Jiangsu Association for Science and Technology
Zitieren
APA
Xue, Y., Huang, Z., Zhu, X., Wang, S., Jiao, Y., Wang, X., Tang, J., Xu, D., Zhang, Y., Wang, Q., Xu, C., Fang, J., & Wang, K. (2026). FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03417
Vancouver
Xue Y, Huang Z, Zhu X, Wang S, Jiao Y, Wang X, et al. FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03417
BibTeX
@article{Xue2026,
author = {Xue, Yan and Huang, Zhihong and Zhu, Xue and Wang, Shuang and Jiao, Yang and Wang, Xun and Tang, Jie and Xu, Dong and Zhang, Yongchang and Wang, Qian and Xu, Chunwei and Fang, Jing and Wang, Ke},
title = {FGF2-Based Cyclic Peptide PET Tracer for Noninvasive Detection of FGFR1 Expression in Non-Small Cell Lung Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03417}
}
EUVIMED